New Jersey Cancer Care and Blood Disorders — Belleville, New Jersey

New Jersey Cancer Care and Blood Disorders is a clinical research site located in Belleville, New Jersey, United States 07109.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

New Jersey Cancer Care and Blood Disorders has participated in 5 clinical trials with 3 currently active.

Therapeutic areas: Non-small Cell Lung Cancer, Advanced or Metastatic Solid Tumors, FGFR Mutations.

Sponsors: EMD Serono Research & Development Institute, Inc., Incyte Corporation, Tempus AI.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Jersey Cancer Care and Blood Disorders?

New Jersey Cancer Care and Blood Disorders has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Jersey Cancer Care and Blood Disorders conducted?

New Jersey Cancer Care and Blood Disorders has 5 clinical trials on record, with 3 currently active. Their work covers Non-small Cell Lung Cancer, Advanced or Metastatic Solid Tumors, FGFR Mutations.

Is New Jersey Cancer Care and Blood Disorders accredited by Crixeo Health?

New Jersey Cancer Care and Blood Disorders has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Jersey Cancer Care and Blood Disorders?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.